Novo Nordisk A/S (B Shares) ADRhedged
NVOH
1 hedge funds and large institutions have $206 invested in Novo Nordisk A/S (B Shares) ADRhedged in 2026 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
0.01% more ownership
Funds ownership: 0% → 0.01% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$256 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $206 | +$256 | +10 | New |
|
NVOH Hedge Fund Activity: Q1 2026 in Review
1 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk A/S (B Shares) ADRhedged (NVOH) for Q1 2026, worth a combined $206.
Buyers outnumbered sellers: 1 fund opened new NVOH positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $256.
- 1 institutional investor held Novo Nordisk A/S (B Shares) ADRhedged (NVOH) as of Q1 2026, up from 0 in Q4 2025.
- Funds reported $206 of Novo Nordisk A/S (B Shares) ADRhedged stock for Q1 2026.
- 1 fund opened new Novo Nordisk A/S (B Shares) ADRhedged positions in Q1 2026 and 0 closed out, a net change of +1 holder.
- The largest Novo Nordisk A/S (B Shares) ADRhedged buyer in Q1 2026 was UBS Group, an estimated $256 added.
Based on aggregated 13F filings for Q1 2026.